Article Details
Retrieved on: 2021-05-26 08:15:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... Pieris Pharmaceuticals has baged $20m upfront for a strategic R&D and license agreement with Genentech, the US branch of Swiss Roche AG.
Article found on: european-biotechnology.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here